hematologic Archives - AudioMedica.com

Tagged: hematologic

- in Oncology
- — 16 Mar, 2008
Audio Journal of Oncology in Advance – March 15th, 2008
Volume 16 Number 6 (March 15th, 2008) reporting from:
4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
Chemotherapy Foundation Symposium, November 7-10, 2007, New York

David Maloney
Nonmyeloablative
…
More
- in Oncology
- — 4 Mar, 2008
Audio Journal of Oncology in Advance – March 1st, 2008
Volume 16 Number 5 (March 1st, 2008) reporting from:
4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
Gastrointestinal Cancers Symposium (January 25-27, 2008, Orlando)
American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)

Richard Stone

George Canellos
…
More
- in General Medicine
- — 27 Feb, 2008
Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

Timothy Illidge
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
TIMOTHY ILLIDGE, Christie Hospital, Manchester
Radioconjugated antibodies are showing great promise for treating follicular lymphoma which has failed chemotherapy combined with rituximab. That’s according to Tim
…
More
- in News · Oncology
- — 26 Feb, 2008
Chronic Lymphocytic Leukemia After Fludarabine Failure

John Gribben
Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
JOHN GRIBBEN, Bartholemews Hospital, London
New promise for treating chronic lymphocytic leukemia is arising from combining antibody therapies rituximab and alemtuzumab with new drugs such as
…
More
- in Oncology
- — 10 Dec, 2007
Live Report from ASH:
Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

Susan O’Brien
SUSAN O’BRIEN, MD Anderson Cancer Center, Houston
For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology
…
More
- in General Medicine
- — 9 Dec, 2007
New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

Terry Gernsheimer
TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
…
More
- in Public Health
- — 9 Dec, 2007
No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

Zakari Aliyu
REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
ZAKARI ALIYU, Howard University, Washington DC
Nigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with
…
More
- in General Medicine
- — 9 Dec, 2007
Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

Bengt Eriksson
REFERENCE: Abstract 6, American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
BENGT ERIKSSON, Gothenburg University
In a large phase III trial of patients having a hip replacement, the oral anticoagulant rivaroxaban has shown significant benefit when
…
More

in AJO · ASCO · Oncology
— 5 Jun, 2006

ASCO Audio Journal of Oncology – June 6th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6

Robert Mayer

Thierry Facon

Ibrahim Yakoub-Agha

Peter Paschka

Robert Mayer of the Dana-Farber Cancer Institute in Boston joins Derek Thorne to discuss the major hematologic malignancy news reported at the 2006 ASCO meeting.

– Older patients with multiple myeloma can

…

in AJO
— 8 Dec, 2005

Audio Journal of Hematologic Malignancy Special Edition 2005

Reporting from:
– Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego
– Lymphoma: The Next Questions, April 8-9, 2005, Fort Lauderdale
– Journal of Clinical Oncology

In this edition:

The newer the better, so they …

Tagged: hematologic

Sign up for AudioMedica.com news